(NASDAQ: PHRM); (OTCBB: UDHI); (OTCBB: ARRT).

RealPennies.com: Turning Pennies into dollars: (NASDAQ: PHRM); (OTCBB: UDHI); (OTCBB: ARRT).

Are you a public company looking for exposure?
Contact RealPennies.com - 1.800.940.6559

For more info: http://phrm.realpennies.com

MethylGene Inc. (TSX: MYG) and Pharmion Corporation (NASDAQ: PHRM)(February 14, 2008)announced that the U.S. Food and Drug Administration (FDA) has designated the Companies' histone deacetylase (HDAC) inhibitor, MGCD0103, as an Orphan Drug for the treatment of acute myelogenous leukemia (AML) in the United States. Criteria for designation require that the product be intended for treatment of a condition affecting fewer than 200,000 people in the United States, and the application must include a rationale for the use of the drug in the rare disease or condition.

Orphan Drug Designation allows special incentives for sponsors planning to test a product for use in a rare disease or condition. These incentives include, tax credits, research and development grant funding, and reduced filing fees at the time of application for marketing approval. Once approved, the product may qualify for seven years of marketing exclusivity in the United States.

About MGCD0103

MGCD0103 is an orally-administered, isotype-selective HDAC inhibitor. The compound is currently in one Phase I combination clinical trial with Taxotere for solid tumors, two Phase I/II combination trials with Vidaza for hematological malignancies and with Gemzar for pancreatic cancer, and five Phase II clinical trials in hematological malignancies.

MGCD0103 has received orphan drug designation from the U.S. Food and Drug Administration (FDA) and has been designated an Orphan Medicinal Product by the EMEA for the treatment of Hodgkin lymphoma and acute myelogenous leukemia.

About Acute Myelogenous Leukemia (AML)

Acute myelogenous leukemia (AML) is a cancer of the blood and bone marrow that is characterized by the rapid proliferation (growth) of abnormal white blood cells. These cells are unable to perform their regular functions and eventually crowd out healthy red and white blood cells. Leukemia cells can also spread to other parts of the body. People afflicted with AML are susceptible to increased risk of infections, anemia and bleeding.

AML is the one of the most common forms of leukemia and occurs most often in older adults - the average age being 65. The American Cancer Society estimates that 13,410 new cases and 8,990 deaths occurred in the United States in 2007.

Although several risk factors for AML have been identified, the specific cause of AML remains unclear. AML is a potentially curable disease; but only a minority of patients are cured with current therapies. Current treatments for AML include chemotherapy, blood transfusions and stem cell transplants.

About MethylGene

MethylGene Inc. (TSX: MYG) is a publicly-traded biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for cancer. The Company's lead product, MGCD0103, is an oral isotype-selective HDAC inhibitor presently in multiple clinical trials for solid tumors and hematological malignancies, including Phase II monotherapy and Phase I and Phase II combination trials with Vidaza , Gemzar and Taxotere . MGCD265 is an oral kinase inhibitor targeting the c-Met, Tie-2, Ron and VEGF receptor tyrosine kinases. In addition, MethylGene's preclinical programs include: MGCD290 an HDAC inhibitor in combination with azoles for fungal infections and a sirtuins program for cancer. MethylGene's development and commercialization partners include Pharmion Corporation, Taiho Pharmaceutical and EnVivo Pharmaceuticals. Please visit our website at www.methylgene.com.

About Pharmion

Pharmion is a leading global oncology company focused on acquiring, developing and commercializing innovative products for the treatment of hematology and oncology patients in the U.S., Europe and additional international markets. Pharmion has a number of products on the market including the world's first approved epigenetic drug, Vidaza , a DNA demethylating agent. For additional information about Pharmion, please visit the company's website at www.pharmion.com.

For more info: http://udhi.realpennies.com

Union Dental Holdings, Inc. (OTCBB: UDHI) (February 14, 2008) a Company that operates and manages a network of dentists throughout the United States for union members, announced earlier today it is making plans to expand its Coral Springs facility to become a Total Service Provider (TSP) and offer all aspects of dentistry in one location for all union members.

Dr. George D. Green, President and CEO, stated: "With the consolidation of the telecoms dental benefits become a very big issue with all union members. UDHI is going to now provide all discounted dental services including Orthodontics, Endodontics, Periodontics, Implants, Pedodontics, Cosmetic Dentistry and eventually Oral Surgery in one location in Coral Springs." Dr. Green further stated: "This will save time and money for all members because they will no longer have to be referred to specialists in other offices. We will have 'one stop shopping' so members won't have to take more time off from work for their dental needs." CWA represents the union employees of the telecom while AFA-CWA represents the flight attendants of such airlines as United, US Airways, Northwest, Aloha, Air Wisconsin, Air Tran, America West, American Eagle, Atlantic Southeast, ATA, Piedmont, Miami Air, Alaska, PSA, Mesa, Mesaba, Midwest, Spirit, Horizon & Hawaiian.

The benefit to Union Dental from representing more than one labor organization in a given area is also beneficial to the unions with which UDHI has contracts. Where a particular organization may have scarce membership numbers in certain (usually rural) areas of the US, these numbers can be bolstered by Union Dental representing more than one labor organization and combining the membership numbers into a level that becomes financially viable for a dental offices' participation on a provider level with UDHI.

About Union Dental Holdings, Inc., Direct Dental Services, Inc. and Union Dental Corp.


Direct Dental Services and Union Dental Corp. are wholly owned subsidiaries. Direct Dental Services provides dentists with "areas of exclusivity" to participate with various unions including the Communications Workers of America (CWA) and the International Brotherhood of Electrical Workers (IBEW), United Association of Plumbers and Pipe Fitters (UA) and The Association of Flight Attendants - Communications Workers of America (AFA-CWA). Direct Dental Services receives annual management fees from the dentists in exchange for practicing in these "areas of exclusivity" where CWA and IBEW members use the dentists' services. Union Dental manages a dental practice in Coral Springs, Florida.

For more info: http://arrt.realpennies.com

AmeriResource Technologies, Inc. (OTCBB: ARRT)(February 14, 2008), a diversified holding company, announced earlier today that its subsidiary, BizAuctions, Inc., increased its listings posted on eBay during the month of January by 27% over listings posted for December 2007.

Delmar Janovec, CEO, comments, "BizAuctions, a Titanium Powerseller on eBay, through its eBay store name: BusinessAuctions, Inc., posted 3,384 item listings for the month of January 2008 -- an increase of 730 listings or approximately 27.5% over the month of December 2007. This increase is indicative of how well BizAuctions' business continues to grow and management's commitment to provide our customers with exemplary service as shown by our customer satisfaction rating on eBay of 99.8% with over 14,400 positive feedbacks." "BizAuctions employs two primary business models, whereby it liquidates inventory through eBay on consignment for a lucrative commission; and/or it purchases inventory at a fraction of retail price for the purpose of liquidating it for a profit. BizAuctions consigns, buys inventory, and liquidates through eBay," continues Janovec.

BizAuctions' clients have included some of the Nation's leading retail names at the forefront of their industries. With a long-term strategy to provide eBay liquidation services to Fortune 1000 enterprises, BizAuctions is a clear and lucrative solution for most any business to liquidate excess inventory on eBay.

BizAuctions' operations are designed for maximum capacity to handle most any eBay liquidation project. Whether the client is a Fortune 500 company with 1,000 items or a small business with 100 items, BizAuctions can take on most any project and recover funds from clients' excess inventory.

More information is available at www.BizAuctions.com. Investors and media can receive a free investor kit for BizAuctions, Inc. by contacting Investor Relations at investors@BizAuctions.com or (800) 961-3275. A virtual tour of BizAuctions' facilities and flash video presentation can be viewed at http://www.bizauctions.com/tour.shtml.

The Company encourages the public to read the above information in conjunction with its year-end 10-KSB for December 31, 2006, and the third Quarter 10-QSB for September 30, 2007. The financial statements can be viewed at www.sec.gov.

ABOUT AMERIRESOURCE

AmeriResource is a diversified holding company with headquarters in Las Vegas, Nevada. It operates BizAuctions, Inc., AuctionWagon Inc., RoboServer Systems Corp., among others as operating subsidiaries. For more information on the Company and its operating subsidiaries, please see the Company's website at http://www.ameriresourcetechnologies.com.

Read our full disclaimer at: http://www.realpennies.com/start.html

Investors are advised that this analysis is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy. This report does not have regard to the specific investment objectives, financial situation and the particular needs of any specific person who may receive this information. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Past performance is no guarantee of future results. Please consult a broker before purchasing or selling any securities mentioned on RealPennies. For more movers: http://www.realpennies.com/wrapup.html

Any opinions expressed herein are statements of our judgment as of the date of publication and are subject to change without notice.
Sitemap: http://www.realpennies.com/sitemap.html

RealPennies .

Telephone: 1-800-940-6559

Matt /at/ realpennies.com